|
|
|
|
|
|
☒
|
Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
||
|
For the quarterly period ended September 30, 2016
|
||
☐
|
Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
||
|
For the transition period from to
|
|
|
|
|
|
|
Delaware
|
|
13-3728359
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
Glenpointe Centre West
500 Frank W. Burr Blvd.
Teaneck, New Jersey
|
|
07666
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
|
|
|
Large accelerated filer
|
☒
|
Accelerated filer
|
☐
|
|
|
|
|
Non-accelerated filer
|
☐ (Do not check if a smaller reporting company)
|
Smaller reporting company
|
☐
|
Class
|
|
Number of Shares
|
Class A Common Stock, par value $.01 per share
|
|
606,704,575
|
|
|
|
|
|
Page
|
PART I.
|
||
|
|
|
Item 1.
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
Item 2.
|
||
|
|
|
Item 3.
|
||
|
|
|
Item 4.
|
||
|
|
|
PART II.
|
||
|
|
|
Item 1.
|
||
|
|
|
Item 1A.
|
||
|
|
|
Item 2.
|
||
|
|
|
Item 5.
|
||
|
|
|
Item 6.
|
||
|
|
|
|
September 30,
2016 |
|
December 31,
2015 |
||||
Assets
|
|
|
|
||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
1,550.3
|
|
|
$
|
2,125.2
|
|
Short-term investments
|
3,308.3
|
|
|
2,824.3
|
|
||
Trade accounts receivable, net of allowances of $45.2 and $39.0, respectively
|
2,492.1
|
|
|
2,252.6
|
|
||
Unbilled accounts receivable
|
423.6
|
|
|
369.0
|
|
||
Other current assets
|
425.5
|
|
|
337.5
|
|
||
Total current assets
|
8,199.8
|
|
|
7,908.6
|
|
||
Property and equipment, net of accumulated depreciation of $1,255.3 and $1,079.1, respectively
|
1,323.3
|
|
|
1,271.4
|
|
||
Goodwill
|
2,482.0
|
|
|
2,404.7
|
|
||
Intangible assets, net
|
936.9
|
|
|
864.3
|
|
||
Deferred income tax assets, net
|
385.3
|
|
|
347.8
|
|
||
Equity method investment
|
60.6
|
|
|
—
|
|
||
Other noncurrent assets
|
328.8
|
|
|
264.2
|
|
||
Total assets
|
$
|
13,716.7
|
|
|
$
|
13,061.0
|
|
Liabilities and Stockholders’ Equity
|
|
|
|
||||
Current liabilities:
|
|
|
|
||||
Accounts payable
|
$
|
171.5
|
|
|
$
|
165.3
|
|
Deferred revenue
|
281.7
|
|
|
323.7
|
|
||
Short-term debt
|
75.0
|
|
|
406.3
|
|
||
Accrued expenses and other current liabilities
|
1,772.5
|
|
|
1,818.4
|
|
||
Total current liabilities
|
2,300.7
|
|
|
2,713.7
|
|
||
Deferred revenue, noncurrent
|
158.3
|
|
|
49.3
|
|
||
Deferred income tax liabilities, net
|
3.7
|
|
|
3.3
|
|
||
Long-term debt
|
821.6
|
|
|
876.8
|
|
||
Other noncurrent liabilities
|
140.1
|
|
|
139.8
|
|
||
Total liabilities
|
3,424.4
|
|
|
3,782.9
|
|
||
Commitments and contingencies (See Note 11)
|
|
|
|
||||
Stockholders’ equity:
|
|
|
|
||||
Preferred stock, $0.10 par value, 15.0 shares authorized, none issued
|
—
|
|
|
—
|
|
||
Class A common stock, $0.01 par value, 1,000.0 shares authorized, 606.6 and 609.0 shares issued and outstanding at September 30, 2016 and December 31, 2015, respectively
|
6.1
|
|
|
6.1
|
|
||
Additional paid-in capital
|
279.2
|
|
|
453.0
|
|
||
Retained earnings
|
10,063.2
|
|
|
8,925.2
|
|
||
Accumulated other comprehensive income (loss)
|
(56.2
|
)
|
|
(106.2
|
)
|
||
Total stockholders’ equity
|
10,292.3
|
|
|
9,278.1
|
|
||
Total liabilities and stockholders’ equity
|
$
|
13,716.7
|
|
|
$
|
13,061.0
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Revenues
|
$
|
3,453.2
|
|
|
$
|
3,187.0
|
|
|
$
|
10,025.1
|
|
|
$
|
9,183.5
|
|
Operating expenses:
|
|
|
|
|
|
|
|
||||||||
Cost of revenues (exclusive of depreciation and amortization expense shown separately below)
|
2,077.4
|
|
|
1,934.6
|
|
|
6,030.5
|
|
|
5,506.6
|
|
||||
Selling, general and administrative expenses
|
700.5
|
|
|
627.1
|
|
|
2,000.6
|
|
|
1,849.9
|
|
||||
Depreciation and amortization expense
|
91.9
|
|
|
82.5
|
|
|
265.7
|
|
|
238.4
|
|
||||
Income from operations
|
583.4
|
|
|
542.8
|
|
|
1,728.3
|
|
|
1,588.6
|
|
||||
Other income (expense), net:
|
|
|
|
|
|
|
|
||||||||
Interest income
|
27.2
|
|
|
20.7
|
|
|
85.4
|
|
|
56.3
|
|
||||
Interest expense
|
(4.9
|
)
|
|
(4.3
|
)
|
|
(14.6
|
)
|
|
(13.4
|
)
|
||||
Foreign currency exchange gains (losses), net
|
6.9
|
|
|
(15.8
|
)
|
|
(4.2
|
)
|
|
(28.4
|
)
|
||||
Other, net
|
0.3
|
|
|
(0.4
|
)
|
|
1.7
|
|
|
(0.7
|
)
|
||||
Total other income (expense), net
|
29.5
|
|
|
0.2
|
|
|
68.3
|
|
|
13.8
|
|
||||
Income before provision for income taxes
|
612.9
|
|
|
543.0
|
|
|
1,796.6
|
|
|
1,602.4
|
|
||||
Provision for income taxes
|
(168.9
|
)
|
|
(145.8
|
)
|
|
(659.2
|
)
|
|
(402.2
|
)
|
||||
Income from equity method investment
|
0.4
|
|
|
—
|
|
|
0.6
|
|
|
—
|
|
||||
Net income
|
$
|
444.4
|
|
|
$
|
397.2
|
|
|
$
|
1,138.0
|
|
|
$
|
1,200.2
|
|
Basic earnings per share
|
$
|
0.73
|
|
|
$
|
0.65
|
|
|
$
|
1.88
|
|
|
$
|
1.97
|
|
Diluted earnings per share
|
$
|
0.73
|
|
|
$
|
0.65
|
|
|
$
|
1.87
|
|
|
$
|
1.96
|
|
Weighted average number of common shares outstanding - Basic
|
606.2
|
|
|
608.8
|
|
|
606.8
|
|
|
609.4
|
|
||||
Dilutive effect of shares issuable under stock-based compensation plans
|
2.3
|
|
|
3.9
|
|
|
2.9
|
|
|
4.1
|
|
||||
Weighted average number of common shares outstanding - Diluted
|
608.5
|
|
|
612.7
|
|
|
609.7
|
|
|
613.5
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Net income
|
$
|
444.4
|
|
|
$
|
397.2
|
|
|
$
|
1,138.0
|
|
|
$
|
1,200.2
|
|
Other comprehensive income (loss), net of tax:
|
|
|
|
|
|
|
|
||||||||
Foreign currency translation adjustments
|
0.5
|
|
|
(16.8
|
)
|
|
(8.6
|
)
|
|
(34.4
|
)
|
||||
Change in unrealized gains and losses on cash flow hedges, net of taxes
|
41.0
|
|
|
(6.8
|
)
|
|
52.4
|
|
|
42.3
|
|
||||
Change in unrealized gains and losses on available-for-sale securities, net of taxes
|
(2.0
|
)
|
|
0.8
|
|
|
6.2
|
|
|
1.9
|
|
||||
Other comprehensive income (loss)
|
39.5
|
|
|
(22.8
|
)
|
|
50.0
|
|
|
9.8
|
|
||||
Comprehensive income
|
$
|
483.9
|
|
|
$
|
374.4
|
|
|
$
|
1,188.0
|
|
|
$
|
1,210.0
|
|
|
For the Nine Months Ended
September 30, |
||||||
|
2016
|
|
2015
|
||||
Cash flows from operating activities:
|
|
|
|
||||
Net income
|
$
|
1,138.0
|
|
|
$
|
1,200.2
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
Depreciation and amortization
|
278.4
|
|
|
242.0
|
|
||
Provision for doubtful accounts
|
9.2
|
|
|
8.4
|
|
||
Deferred income taxes
|
(44.2
|
)
|
|
(107.3
|
)
|
||
Stock-based compensation expense
|
165.4
|
|
|
141.6
|
|
||
Excess tax benefits on stock-based compensation plans
|
(19.0
|
)
|
|
(19.0
|
)
|
||
Other
|
9.2
|
|
|
27.9
|
|
||
Changes in assets and liabilities:
|
|
|
|
||||
Trade accounts receivable
|
(261.2
|
)
|
|
(190.6
|
)
|
||
Other current assets
|
(84.2
|
)
|
|
(7.6
|
)
|
||
Other noncurrent assets
|
(51.0
|
)
|
|
(40.1
|
)
|
||
Accounts payable
|
11.9
|
|
|
16.8
|
|
||
Deferred revenues, current and noncurrent
|
(57.2
|
)
|
|
11.5
|
|
||
Other current and noncurrent liabilities
|
(72.9
|
)
|
|
179.5
|
|
||
Net cash provided by operating activities
|
1,022.4
|
|
|
1,463.3
|
|
||
Cash flows from investing activities:
|
|
|
|
||||
Purchases of property and equipment
|
(212.8
|
)
|
|
(198.7
|
)
|
||
Purchases of investments
|
(4,215.5
|
)
|
|
(2,093.9
|
)
|
||
Proceeds from maturity or sale of investments
|
3,740.6
|
|
|
1,262.2
|
|
||
Payments for business combinations, net of cash acquired and equity method investment
|
(185.0
|
)
|
|
—
|
|
||
Net cash (used in) investing activities
|
(872.7
|
)
|
|
(1,030.4
|
)
|
||
Cash flows from financing activities:
|
|
|
|
||||
Issuance of common stock under stock-based compensation plans
|
134.6
|
|
|
98.9
|
|
||
Excess tax benefits on stock-based compensation plans
|
19.0
|
|
|
19.0
|
|
||
Repurchases of common stock
|
(492.2
|
)
|
|
(383.2
|
)
|
||
Repayment of term loan borrowings and capital lease obligations
|
(41.0
|
)
|
|
(39.6
|
)
|
||
Net change in notes outstanding under the revolving credit facility
|
(350.0
|
)
|
|
(650.0
|
)
|
||
Net cash (used in) financing activities
|
(729.6
|
)
|
|
(954.9
|
)
|
||
Effect of exchange rate changes on cash and cash equivalents
|
5.0
|
|
|
(11.4
|
)
|
||
(Decrease) in cash and cash equivalents
|
(574.9
|
)
|
|
(533.4
|
)
|
||
Cash and cash equivalents, beginning of year
|
2,125.2
|
|
|
2,010.1
|
|
||
Cash and cash equivalents, end of period
|
$
|
1,550.3
|
|
|
$
|
1,476.7
|
|
|
Fair Value
|
|
Weighted Average Useful Life
|
|
|
(in millions)
|
|
|
|
Non-deductible goodwill
|
75.0
|
|
|
|
Customer relationship intangible assets
|
152.8
|
|
|
7.1 years
|
Other intangible assets
|
0.7
|
|
|
3.9 years
|
|
September 30, 2016
|
|
December 31, 2015
|
||||
|
(in millions)
|
||||||
Trading investment securities:
|
|
|
|
||||
Mutual funds
|
$
|
25.0
|
|
|
$
|
—
|
|
Total trading investment securities
|
25.0
|
|
|
—
|
|
||
Available-for-sale investment securities:
|
|
|
|
||||
U.S. Treasury and agency debt securities
|
616.2
|
|
|
527.1
|
|
||
Corporate and other debt securities
|
411.2
|
|
|
360.5
|
|
||
Certificates of deposit and commercial paper
|
1,032.7
|
|
|
754.0
|
|
||
Asset-backed securities
|
220.4
|
|
|
229.6
|
|
||
Municipal debt securities
|
114.7
|
|
|
121.3
|
|
||
Mutual funds
|
—
|
|
|
22.3
|
|
||
Total available-for-sale investment securities
|
2,395.2
|
|
|
2,014.8
|
|
||
Held-to-maturity investment securities:
|
|
|
|
||||
Certificates of deposit and commercial paper
|
29.5
|
|
|
—
|
|
||
Total held-to-maturity investment securities
|
29.5
|
|
|
—
|
|
||
Other investments:
|
|
|
|
||||
Time deposits
|
858.6
|
|
|
809.5
|
|
||
Total other investments
|
858.6
|
|
|
809.5
|
|
||
Total short-term investments
|
$
|
3,308.3
|
|
|
$
|
2,824.3
|
|
|
Amortized
Cost
|
|
Unrealized
Gains
|
|
Unrealized
Losses
|
|
Fair
Value |
||||||||
|
(in millions)
|
||||||||||||||
U.S. Treasury and agency debt securities
|
$
|
615.5
|
|
|
$
|
1.0
|
|
|
$
|
(0.3
|
)
|
|
$
|
616.2
|
|
Corporate and other debt securities
|
410.3
|
|
|
1.1
|
|
|
(0.2
|
)
|
|
411.2
|
|
||||
Certificates of deposit and commercial paper
|
1,032.3
|
|
|
0.8
|
|
|
(0.4
|
)
|
|
1,032.7
|
|
||||
Asset-backed securities
|
220.1
|
|
|
0.4
|
|
|
(0.1
|
)
|
|
220.4
|
|
||||
Municipal debt securities
|
114.5
|
|
|
0.3
|
|
|
(0.1
|
)
|
|
114.7
|
|
||||
Total available-for-sale investment securities
|
$
|
2,392.7
|
|
|
$
|
3.6
|
|
|
$
|
(1.1
|
)
|
|
$
|
2,395.2
|
|
|
Amortized
Cost
|
|
Unrealized
Gains
|
|
Unrealized
Losses
|
|
Fair
Value
|
||||||||
|
(in millions)
|
||||||||||||||
U.S. Treasury and agency debt securities
|
$
|
528.9
|
|
|
$
|
—
|
|
|
$
|
(1.8
|
)
|
|
$
|
527.1
|
|
Corporate and other debt securities
|
361.9
|
|
|
0.1
|
|
|
(1.5
|
)
|
|
360.5
|
|
||||
Certificates of deposit and commercial paper
|
754.0
|
|
|
0.1
|
|
|
(0.1
|
)
|
|
754.0
|
|
||||
Asset-backed securities
|
230.3
|
|
|
0.1
|
|
|
(0.8
|
)
|
|
229.6
|
|
||||
Municipal debt securities
|
121.2
|
|
|
0.2
|
|
|
(0.1
|
)
|
|
121.3
|
|
||||
Mutual funds
|
25.3
|
|
|
0.1
|
|
|
(3.1
|
)
|
|
22.3
|
|
||||
Total available-for-sale investment securities
|
$
|
2,021.6
|
|
|
$
|
0.6
|
|
|
$
|
(7.4
|
)
|
|
$
|
2,014.8
|
|
|
Less than 12 Months
|
|
12 Months or More
|
|
Total
|
||||||||||||||||||
|
Fair
Value
|
|
Unrealized
Losses
|
|
Fair
Value
|
|
Unrealized
Losses
|
|
Fair
Value
|
|
Unrealized
Losses
|
||||||||||||
|
(in millions)
|
||||||||||||||||||||||
U.S. Treasury and agency debt securities
|
$
|
210.6
|
|
|
$
|
(0.3
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
210.6
|
|
|
$
|
(0.3
|
)
|
Corporate and other debt securities
|
116.9
|
|
|
(0.2
|
)
|
|
0.9
|
|
|
—
|
|
|
117.8
|
|
|
(0.2
|
)
|
||||||
Certificates of deposit and commercial paper
|
368.1
|
|
|
(0.4
|
)
|
|
—
|
|
|
—
|
|
|
368.1
|
|
|
(0.4
|
)
|
||||||
Asset-backed securities
|
62.8
|
|
|
(0.1
|
)
|
|
0.6
|
|
|
—
|
|
|
63.4
|
|
|
(0.1
|
)
|
||||||
Municipal debt securities
|
43.0
|
|
|
(0.1
|
)
|
|
0.6
|
|
|
—
|
|
|
43.6
|
|
|
(0.1
|
)
|
||||||
Total
|
$
|
801.4
|
|
|
$
|
(1.1
|
)
|
|
$
|
2.1
|
|
|
$
|
—
|
|
|
$
|
803.5
|
|
|
$
|
(1.1
|
)
|
|
Less than 12 Months
|
|
12 Months or More
|
|
Total
|
||||||||||||||||||
|
Fair
Value
|
|
Unrealized
Losses
|
|
Fair
Value
|
|
Unrealized
Losses
|
|
Fair
Value
|
|
Unrealized
Losses
|
||||||||||||
|
(in millions)
|
||||||||||||||||||||||
U.S. Treasury and agency debt securities
|
$
|
475.7
|
|
|
$
|
(1.8
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
475.7
|
|
|
$
|
(1.8
|
)
|
Corporate and other debt securities
|
315.1
|
|
|
(1.5
|
)
|
|
3.1
|
|
|
—
|
|
|
318.2
|
|
|
(1.5
|
)
|
||||||
Certificates of deposit and commercial paper
|
271.5
|
|
|
(0.1
|
)
|
|
—
|
|
|
—
|
|
|
271.5
|
|
|
(0.1
|
)
|
||||||
Asset-backed securities
|
199.4
|
|
|
(0.7
|
)
|
|
11.4
|
|
|
(0.1
|
)
|
|
210.8
|
|
|
(0.8
|
)
|
||||||
Municipal debt securities
|
56.5
|
|
|
(0.1
|
)
|
|
—
|
|
|
—
|
|
|
56.5
|
|
|
(0.1
|
)
|
||||||
Mutual funds
|
—
|
|
|
—
|
|
|
21.1
|
|
|
(3.1
|
)
|
|
21.1
|
|
|
(3.1
|
)
|
||||||
Total
|
$
|
1,318.2
|
|
|
$
|
(4.2
|
)
|
|
$
|
35.6
|
|
|
$
|
(3.2
|
)
|
|
$
|
1,353.8
|
|
|
$
|
(7.4
|
)
|
|
Amortized
Cost
|
|
Fair
Value
|
||||
|
(in millions)
|
||||||
Due within one year
|
$
|
1,199.2
|
|
|
$
|
1,199.6
|
|
Due after one year up to two years
|
498.6
|
|
|
499.2
|
|
||
Due after two years up to three years
|
373.5
|
|
|
374.5
|
|
||
Due after three years up to four years
|
101.3
|
|
|
101.5
|
|
||
Asset-backed securities
|
220.1
|
|
|
220.4
|
|
||
Fixed income available-for-sale investment securities
|
$
|
2,392.7
|
|
|
$
|
2,395.2
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
|
(in millions)
|
||||||||||||||
Proceeds from sales of available-for-sale investment securities
|
$
|
464.7
|
|
|
$
|
168.3
|
|
|
$
|
2,842.8
|
|
|
$
|
596.4
|
|
|
|
|
|
|
|
|
|
||||||||
Gross gains
|
$
|
0.5
|
|
|
$
|
0.2
|
|
|
$
|
5.0
|
|
|
$
|
1.1
|
|
Gross losses
|
(3.2
|
)
|
|
(0.1
|
)
|
|
(3.6
|
)
|
|
(0.2
|
)
|
||||
Net realized (losses) gains on sales of available-for-sale investment securities
|
$
|
(2.7
|
)
|
|
$
|
0.1
|
|
|
$
|
1.4
|
|
|
$
|
0.9
|
|
|
Amortized
Cost |
|
Unrealized
Gains |
|
Unrealized
Losses |
|
Fair
Value |
||||||||
|
(in millions)
|
||||||||||||||
Certificates of deposit and commercial paper
|
29.5
|
|
|
—
|
|
|
—
|
|
|
29.5
|
|
||||
Total held-to-maturity investment securities
|
$
|
29.5
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
29.5
|
|
|
September 30, 2016
|
|
December 31, 2015
|
||||
|
(in millions)
|
||||||
Compensation and benefits
|
$
|
1,116.7
|
|
|
$
|
1,272.0
|
|
Income taxes
|
14.7
|
|
|
17.1
|
|
||
Professional fees
|
88.9
|
|
|
69.6
|
|
||
Travel and entertainment
|
36.9
|
|
|
29.8
|
|
||
Customer volume incentives
|
235.1
|
|
|
236.1
|
|
||
Derivative financial instruments
|
4.5
|
|
|
10.9
|
|
||
Other
|
275.7
|
|
|
182.9
|
|
||
Total accrued expenses and other current liabilities
|
$
|
1,772.5
|
|
|
$
|
1,818.4
|
|
|
|
September 30, 2016
|
|
December 31, 2015
|
||||
|
|
(in millions)
|
||||||
Notes outstanding under revolving credit facility
|
|
$
|
—
|
|
|
$
|
350.0
|
|
Term loan - current maturities
|
|
75.0
|
|
|
56.3
|
|
||
Total short-term debt
|
|
$
|
75.0
|
|
|
$
|
406.3
|
|
|
|
September 30, 2016
|
|
December 31, 2015
|
||||
|
|
(in millions)
|
||||||
Term loan, due 2019
|
|
$
|
900.0
|
|
|
$
|
937.5
|
|
Less:
|
|
|
|
|
||||
Current maturities
|
|
(75.0
|
)
|
|
(56.3
|
)
|
||
Deferred financing costs
|
|
(3.4
|
)
|
|
(4.4
|
)
|
||
Long-term debt, net
|
|
$
|
821.6
|
|
|
$
|
876.8
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||
Effective income tax rate
|
27.6
|
%
|
|
26.9
|
%
|
|
36.7
|
%
|
|
25.1
|
%
|
|
|
|
|
September 30, 2016
|
|
December 31, 2015
|
||||||||||||
Designation of Derivatives
|
|
Location on Statement of
Financial Position
|
|
Assets
|
|
Liabilities
|
|
Assets
|
|
Liabilities
|
||||||||
|
|
|
|
(in millions)
|
||||||||||||||
Foreign exchange forward contracts – Designated as cash flow hedging instruments
|
|
Other current assets
|
|
$
|
37.5
|
|
|
$
|
—
|
|
|
$
|
7.2
|
|
|
$
|
—
|
|
|
|
Other noncurrent assets
|
|
16.8
|
|
|
—
|
|
|
1.6
|
|
|
—
|
|
||||
|
|
Accrued expenses and other current liabilities
|
|
—
|
|
|
0.4
|
|
|
—
|
|
|
9.7
|
|
||||
|
|
Other noncurrent liabilities
|
|
—
|
|
|
0.1
|
|
|
—
|
|
|
13.5
|
|
||||
|
|
Total
|
|
54.3
|
|
|
0.5
|
|
|
8.8
|
|
|
23.2
|
|
||||
Foreign exchange forward contracts – Not designated as hedging instruments
|
|
Other current assets
|
|
—
|
|
|
—
|
|
|
0.4
|
|
|
—
|
|
||||
|
|
Accrued expenses and other current liabilities
|
|
—
|
|
|
4.1
|
|
|
—
|
|
|
1.2
|
|
||||
|
|
Total
|
|
—
|
|
|
4.1
|
|
|
0.4
|
|
|
1.2
|
|
||||
Total
|
|
|
|
$
|
54.3
|
|
|
$
|
4.6
|
|
|
$
|
9.2
|
|
|
$
|
24.4
|
|
|
September 30, 2016
|
|
December 31, 2015
|
||||
|
(in millions)
|
||||||
2016
|
$
|
315.0
|
|
|
$
|
1,215.0
|
|
2017
|
1,125.0
|
|
|
900.0
|
|
||
2018
|
495.0
|
|
|
330.0
|
|
||
Total notional value of contracts outstanding
|
$
|
1,935.0
|
|
|
$
|
2,445.0
|
|
Net unrealized gains (losses) included in accumulated other comprehensive income (loss), net of taxes
|
$
|
40.7
|
|
|
$
|
(11.7
|
)
|
|
Change in
Derivative Gains/Losses Recognized
in Accumulated Other
Comprehensive Income (Loss)
(effective portion)
|
|
Location of Net Derivative Gains (Losses) Reclassified
from Accumulated Other
Comprehensive Income (Loss)
into Income
(effective portion)
|
|
Net Gain (Loss) Reclassified
from Accumulated Other
Comprehensive Income (Loss)
into Income
(effective portion)
|
||||||||||||
|
2016
|
|
2015
|
|
|
|
2016
|
|
2015
|
||||||||
|
(in millions)
|
||||||||||||||||
Foreign exchange forward contracts – Designated as cash flow hedging instruments
|
$
|
63.2
|
|
|
$
|
(29.1
|
)
|
|
Cost of revenues
|
|
$
|
7.4
|
|
|
$
|
(17.5
|
)
|
|
|
|
|
|
Selling, general and administrative expenses
|
|
1.4
|
|
|
(3.4
|
)
|
||||||
|
|
|
|
|
Total
|
|
$
|
8.8
|
|
|
$
|
(20.9
|
)
|
|
Change in
Derivative Gains/Losses Recognized
in Accumulated Other
Comprehensive Income (Loss)
(effective portion)
|
|
Location of Net Derivative Gains (Losses) Reclassified
from Accumulated Other
Comprehensive Income (Loss)
into Income
(effective portion)
|
|
Net Gain (Loss) Reclassified
from Accumulated Other
Comprehensive Income (Loss)
into Income
(effective portion)
|
||||||||||||
|
2016
|
|
2015
|
|
|
|
2016
|
|
2015
|
||||||||
|
(in millions)
|
||||||||||||||||
Foreign exchange forward contracts – Designated as cash flow hedging instruments
|
$
|
77.7
|
|
|
$
|
(3.4
|
)
|
|
Cost of revenues
|
|
$
|
8.0
|
|
|
$
|
(42.8
|
)
|
|
|
|
|
|
Selling, general and administrative expenses
|
|
1.5
|
|
|
(9.0
|
)
|
||||||
|
|
|
|
|
Total
|
|
$
|
9.5
|
|
|
$
|
(51.8
|
)
|
|
September 30, 2016
|
|
December 31, 2015
|
||||||||||||
|
Notional
|
|
Market Value
|
|
|
Notional
|
|
Market Value
|
|
||||||
|
(in millions)
|
||||||||||||||
Contracts outstanding
|
$
|
195.6
|
|
|
$
|
(4.1
|
)
|
|
$
|
165.5
|
|
|
$
|
(0.8
|
)
|
•
|
Level 1 – Inputs are quoted prices in active markets for identical assets or liabilities.
|
•
|
Level 2 – Inputs are quoted prices for similar assets or liabilities in an active market, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable and market-corroborated inputs which are derived principally from or corroborated by observable market data.
|
•
|
Level 3 – Inputs are derived from valuation techniques in which one or more significant inputs or value drivers are unobservable.
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
|
(in millions)
|
||||||||||||||
Cash equivalents:
|
|
|
|
|
|
|
|
||||||||
Money market funds
|
$
|
263.8
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
263.8
|
|
Total cash equivalents
|
263.8
|
|
|
—
|
|
|
—
|
|
|
263.8
|
|
||||
Short-term investments:
|
|
|
|
|
|
|
|
||||||||
Time deposits
|
—
|
|
|
858.6
|
|
|
—
|
|
|
858.6
|
|
||||
Available-for-sale investment securities:
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury and agency debt securities
|
568.3
|
|
|
47.9
|
|
|
—
|
|
|
616.2
|
|
||||
Corporate and other debt securities
|
—
|
|
|
411.2
|
|
|
—
|
|
|
411.2
|
|
||||
Certificates of deposit and commercial paper
|
—
|
|
|
1,032.7
|
|
|
—
|
|
|
1,032.7
|
|
||||
Asset-backed securities
|
—
|
|
|
220.4
|
|
|
—
|
|
|
220.4
|
|
||||
Municipal debt securities
|
—
|
|
|
114.7
|
|
|
—
|
|
|
114.7
|
|
||||
Total available-for-sale investment securities
|
568.3
|
|
|
1,826.9
|
|
|
—
|
|
|
2,395.2
|
|
||||
Held-to-maturity investment securities:
|
|
|
|
|
|
|
|
||||||||
Certificates of deposit and commercial paper
|
—
|
|
|
29.5
|
|
|
—
|
|
|
29.5
|
|
||||
Total held-to-maturity investment securities
|
—
|
|
|
29.5
|
|
|
—
|
|
|
29.5
|
|
||||
Total short-term investments
(1)
|
568.3
|
|
|
2,715.0
|
|
|
—
|
|
|
3,283.3
|
|
||||
Derivative financial instruments - foreign exchange forward contracts:
|
|
|
|
|
|
|
|
||||||||
Other current assets
|
—
|
|
|
37.5
|
|
|
—
|
|
|
37.5
|
|
||||
Accrued expenses and other current liabilities
|
—
|
|
|
(4.5
|
)
|
|
—
|
|
|
(4.5
|
)
|
||||
Other noncurrent assets
|
—
|
|
|
16.8
|
|
|
—
|
|
|
16.8
|
|
||||
Other noncurrent liabilities
|
—
|
|
|
(0.1
|
)
|
|
—
|
|
|
(0.1
|
)
|
||||
Total
|
$
|
832.1
|
|
|
$
|
2,764.7
|
|
|
$
|
—
|
|
|
$
|
3,596.8
|
|
(1)
|
Excludes trading securities in mutual funds valued at
$25.0 million
based on the net asset value, or NAV, of the fund at September 30, 2016.
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
|
(in millions)
|
||||||||||||||
Cash equivalents:
|
|
|
|
|
|
|
|
||||||||
Money market funds
|
$
|
495.9
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
495.9
|
|
Total cash equivalents
|
495.9
|
|
|
—
|
|
|
—
|
|
|
495.9
|
|
||||
Short-term investments:
|
|
|
|
|
|
|
|
||||||||
Time deposits
|
—
|
|
|
809.5
|
|
|
—
|
|
|
809.5
|
|
||||
Available-for-sale investment securities:
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury and agency debt securities
|
463.7
|
|
|
63.4
|
|
|
—
|
|
|
527.1
|
|
||||
Corporate and other debt securities
|
—
|
|
|
360.5
|
|
|
—
|
|
|
360.5
|
|
||||
Certificates of deposit and commercial paper
|
—
|
|
|
754.0
|
|
|
—
|
|
|
754.0
|
|
||||
Asset-backed securities
|
—
|
|
|
229.6
|
|
|
—
|
|
|
229.6
|
|
||||
Municipal debt securities
|
—
|
|
|
121.3
|
|
|
—
|
|
|
121.3
|
|
||||
Total available-for-sale investment securities
(1)
|
463.7
|
|
|
1,528.8
|
|
|
—
|
|
|
1,992.5
|
|
||||
Total short-term investments
(1)
|
463.7
|
|
|
2,338.3
|
|
|
—
|
|
|
2,802.0
|
|
||||
Derivative financial instruments - foreign exchange forward contracts:
|
|
|
|
|
|
|
|
||||||||
Other current assets
|
—
|
|
|
7.6
|
|
|
—
|
|
|
7.6
|
|
||||
Accrued expenses and other current liabilities
|
—
|
|
|
(10.9
|
)
|
|
—
|
|
|
(10.9
|
)
|
||||
Other noncurrent assets
|
—
|
|
|
1.6
|
|
|
—
|
|
|
1.6
|
|
||||
Other noncurrent liabilities
|
—
|
|
|
(13.5
|
)
|
|
—
|
|
|
(13.5
|
)
|
||||
Total
|
$
|
959.6
|
|
|
$
|
2,323.1
|
|
|
$
|
—
|
|
|
$
|
3,282.7
|
|
(1)
|
Excludes mutual funds valued at
$22.3 million
based on the net asset value, or NAV, of the fund at December 31, 2015.
|
|
Three Months
|
|
Nine Months
|
||||||||||||||||||||
|
Before Tax
Amount
|
|
Tax
Effect
|
|
Net of Tax
Amount
|
|
Before Tax
Amount |
|
Tax
Effect |
|
Net of Tax
Amount |
||||||||||||
|
(in millions)
|
||||||||||||||||||||||
Foreign currency translation adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Beginning balance
|
$
|
(99.0
|
)
|
|
$
|
—
|
|
|
$
|
(99.0
|
)
|
|
$
|
(89.9
|
)
|
|
$
|
—
|
|
|
$
|
(89.9
|
)
|
Change in foreign currency translation adjustments
|
0.5
|
|
|
—
|
|
|
0.5
|
|
|
(8.6
|
)
|
|
—
|
|
|
(8.6
|
)
|
||||||
Ending balance
|
$
|
(98.5
|
)
|
|
$
|
—
|
|
|
$
|
(98.5
|
)
|
|
$
|
(98.5
|
)
|
|
$
|
—
|
|
|
$
|
(98.5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Unrealized gains (losses) on available-for-sale investment securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Beginning balance
|
$
|
5.7
|
|
|
$
|
(2.1
|
)
|
|
$
|
3.6
|
|
|
$
|
(6.8
|
)
|
|
$
|
2.2
|
|
|
$
|
(4.6
|
)
|
Net unrealized gains arising during the period
|
(2.9
|
)
|
|
1.1
|
|
|
(1.8
|
)
|
|
10.7
|
|
|
(3.4
|
)
|
|
7.3
|
|
||||||
Reclassification of net (gains) to Other, net
|
(0.3
|
)
|
|
0.1
|
|
|
(0.2
|
)
|
|
(1.4
|
)
|
|
0.3
|
|
|
(1.1
|
)
|
||||||
Net change
|
(3.2
|
)
|
|
1.2
|
|
|
(2.0
|
)
|
|
9.3
|
|
|
(3.1
|
)
|
|
6.2
|
|
||||||
Ending balance
|
$
|
2.5
|
|
|
$
|
(0.9
|
)
|
|
$
|
1.6
|
|
|
$
|
2.5
|
|
|
$
|
(0.9
|
)
|
|
$
|
1.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Unrealized gains (losses) on cash flow hedges:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Beginning balance
|
$
|
(0.6
|
)
|
|
$
|
0.3
|
|
|
$
|
(0.3
|
)
|
|
$
|
(14.4
|
)
|
|
$
|
2.7
|
|
|
$
|
(11.7
|
)
|
Unrealized gains (losses) arising during the period
|
63.2
|
|
|
(15.3
|
)
|
|
47.9
|
|
|
77.7
|
|
|
(17.8
|
)
|
|
59.9
|
|
||||||
Reclassifications of gains to:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Cost of revenues
|
(7.4
|
)
|
|
1.6
|
|
|
(5.8
|
)
|
|
(8.0
|
)
|
|
1.7
|
|
|
(6.3
|
)
|
||||||
Selling, general and administrative expenses
|
(1.4
|
)
|
|
0.3
|
|
|
(1.1
|
)
|
|
(1.5
|
)
|
|
0.3
|
|
|
(1.2
|
)
|
||||||
Net change
|
54.4
|
|
|
(13.4
|
)
|
|
41.0
|
|
|
68.2
|
|
|
(15.8
|
)
|
|
52.4
|
|
||||||
Ending balance
|
$
|
53.8
|
|
|
$
|
(13.1
|
)
|
|
$
|
40.7
|
|
|
$
|
53.8
|
|
|
$
|
(13.1
|
)
|
|
$
|
40.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Accumulated other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Beginning balance
|
$
|
(93.9
|
)
|
|
$
|
(1.8
|
)
|
|
$
|
(95.7
|
)
|
|
$
|
(111.1
|
)
|
|
$
|
4.9
|
|
|
$
|
(106.2
|
)
|
Other comprehensive income (loss)
|
51.7
|
|
|
(12.2
|
)
|
|
39.5
|
|
|
68.9
|
|
|
(18.9
|
)
|
|
50.0
|
|
||||||
Ending balance
|
$
|
(42.2
|
)
|
|
$
|
(14.0
|
)
|
|
$
|
(56.2
|
)
|
|
$
|
(42.2
|
)
|
|
$
|
(14.0
|
)
|
|
$
|
(56.2
|
)
|
|
Three Months
|
|
Nine Months
|
||||||||||||||||||||
|
Before Tax
Amount
|
|
Tax
Effect
|
|
Net of Tax
Amount
|
|
Before Tax
Amount |
|
Tax
Effect |
|
Net of Tax
Amount |
||||||||||||
|
(in millions)
|
||||||||||||||||||||||
Foreign currency translation adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Beginning balance
|
$
|
(52.4
|
)
|
|
$
|
—
|
|
|
$
|
(52.4
|
)
|
|
$
|
(34.8
|
)
|
|
$
|
—
|
|
|
$
|
(34.8
|
)
|
Change in foreign currency translation adjustments
|
(16.8
|
)
|
|
—
|
|
|
(16.8
|
)
|
|
(34.4
|
)
|
|
—
|
|
|
(34.4
|
)
|
||||||
Ending balance
|
$
|
(69.2
|
)
|
|
$
|
—
|
|
|
$
|
(69.2
|
)
|
|
$
|
(69.2
|
)
|
|
$
|
—
|
|
|
$
|
(69.2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Unrealized gains (losses) on available-for-sale investment securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Beginning balance
|
$
|
(0.5
|
)
|
|
$
|
—
|
|
|
$
|
(0.5
|
)
|
|
$
|
(2.4
|
)
|
|
$
|
0.8
|
|
|
$
|
(1.6
|
)
|
Net unrealized gains arising during the period
|
1.4
|
|
|
(0.6
|
)
|
|
0.8
|
|
|
4.0
|
|
|
(1.8
|
)
|
|
2.2
|
|
||||||
Reclassification of net (gains) to Other, net
|
(0.2
|
)
|
|
0.2
|
|
|
—
|
|
|
(0.9
|
)
|
|
0.6
|
|
|
(0.3
|
)
|
||||||
Net change
|
1.2
|
|
|
(0.4
|
)
|
|
0.8
|
|
|
3.1
|
|
|
(1.2
|
)
|
|
1.9
|
|
||||||
Ending balance
|
$
|
0.7
|
|
|
$
|
(0.4
|
)
|
|
$
|
0.3
|
|
|
$
|
0.7
|
|
|
$
|
(0.4
|
)
|
|
$
|
0.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Unrealized (losses) on cash flow hedges:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Beginning balance
|
$
|
(46.0
|
)
|
|
$
|
8.4
|
|
|
$
|
(37.6
|
)
|
|
$
|
(102.6
|
)
|
|
$
|
15.9
|
|
|
$
|
(86.7
|
)
|
Net unrealized (losses) arising during the period
|
(29.1
|
)
|
|
5.2
|
|
|
(23.9
|
)
|
|
(3.4
|
)
|
|
3.2
|
|
|
(0.2
|
)
|
||||||
Reclassifications of losses to:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Cost of revenues
|
17.5
|
|
|
(3.2
|
)
|
|
14.3
|
|
|
42.8
|
|
|
(7.7
|
)
|
|
35.1
|
|
||||||
Selling, general and administrative expenses
|
3.4
|
|
|
(0.6
|
)
|
|
2.8
|
|
|
9.0
|
|
|
(1.6
|
)
|
|
7.4
|
|
||||||
Net change
|
(8.2
|
)
|
|
1.4
|
|
|
(6.8
|
)
|
|
48.4
|
|
|
(6.1
|
)
|
|
42.3
|
|
||||||
Ending balance
|
$
|
(54.2
|
)
|
|
$
|
9.8
|
|
|
$
|
(44.4
|
)
|
|
$
|
(54.2
|
)
|
|
$
|
9.8
|
|
|
$
|
(44.4
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Accumulated other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Beginning balance
|
$
|
(98.9
|
)
|
|
$
|
8.4
|
|
|
$
|
(90.5
|
)
|
|
$
|
(139.8
|
)
|
|
$
|
16.7
|
|
|
$
|
(123.1
|
)
|
Other comprehensive income (loss)
|
(23.8
|
)
|
|
1.0
|
|
|
(22.8
|
)
|
|
17.1
|
|
|
(7.3
|
)
|
|
9.8
|
|
||||||
Ending balance
|
$
|
(122.7
|
)
|
|
$
|
9.4
|
|
|
$
|
(113.3
|
)
|
|
$
|
(122.7
|
)
|
|
$
|
9.4
|
|
|
$
|
(113.3
|
)
|
•
|
Financial Services, which includes customers providing banking/transaction processing, capital markets and insurance services;
|
•
|
Healthcare, which includes healthcare providers and payers as well as life sciences customers, including pharmaceutical, biotech and medical device companies;
|
•
|
Manufacturing/Retail/Logistics, which includes consumer goods, manufacturers, retailers, travel and other hospitality customers, as well as customers providing logistics services; and
|
•
|
Other, which is an aggregation of industry segments each of which, individually, represents less than
10%
of consolidated revenues and segment operating profit. The Other reportable segment includes our information, media and entertainment services, communications and high technology operating segments.
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
|
(in millions)
|
||||||||||||||
Revenues:
|
|
|
|
|
|
|
|
||||||||
Financial Services
|
$
|
1,375.4
|
|
|
$
|
1,284.0
|
|
|
$
|
4,012.3
|
|
|
$
|
3,695.2
|
|
Healthcare
|
992.8
|
|
|
939.2
|
|
|
2,865.7
|
|
|
2,715.6
|
|
||||
Manufacturing/Retail/Logistics
|
678.7
|
|
|
606.2
|
|
|
1,971.6
|
|
|
1,733.4
|
|
||||
Other
|
406.3
|
|
|
357.6
|
|
|
1,175.5
|
|
|
1,039.3
|
|
||||
Total revenue
|
$
|
3,453.2
|
|
|
$
|
3,187.0
|
|
|
$
|
10,025.1
|
|
|
$
|
9,183.5
|
|
Segment Operating Profit:
|
|
|
|
|
|
|
|
||||||||
Financial Services
|
$
|
433.1
|
|
|
$
|
430.0
|
|
|
$
|
1,315.4
|
|
|
$
|
1,197.5
|
|
Healthcare
|
314.2
|
|
|
322.8
|
|
|
879.4
|
|
|
885.4
|
|
||||
Manufacturing/Retail/Logistics
|
213.5
|
|
|
215.5
|
|
|
658.8
|
|
|
598.0
|
|
||||
Other
|
118.4
|
|
|
117.3
|
|
|
374.0
|
|
|
332.2
|
|
||||
Total segment operating profit
|
1,079.2
|
|
|
1,085.6
|
|
|
3,227.6
|
|
|
3,013.1
|
|
||||
Less: unallocated costs
|
495.8
|
|
|
542.8
|
|
|
1,499.3
|
|
|
1,424.5
|
|
||||
Income from operations
|
$
|
583.4
|
|
|
$
|
542.8
|
|
|
$
|
1,728.3
|
|
|
$
|
1,588.6
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
|
(in millions)
|
||||||||||||||
Revenues:
(1)
|
|
|
|
|
|
|
|
||||||||
North America
(2)
|
$
|
2,709.4
|
|
|
$
|
2,510.6
|
|
|
$
|
7,830.8
|
|
|
$
|
7,226.5
|
|
United Kingdom
|
293.0
|
|
|
299.9
|
|
|
902.5
|
|
|
882.6
|
|
||||
Rest of Europe
|
244.7
|
|
|
209.2
|
|
|
707.8
|
|
|
604.7
|
|
||||
Europe - Total
|
537.7
|
|
|
509.1
|
|
|
1,610.3
|
|
|
1,487.3
|
|
||||
Rest of World
(3)
|
206.1
|
|
|
167.3
|
|
|
584.0
|
|
|
469.7
|
|
||||
Total
|
$
|
3,453.2
|
|
|
$
|
3,187.0
|
|
|
$
|
10,025.1
|
|
|
$
|
9,183.5
|
|
|
As of
|
||||||
|
September 30, 2016
|
|
December 31, 2015
|
||||
|
(in millions)
|
||||||
Long-lived Assets:
(4)
|
|
|
|
||||
North America
(2)
|
$
|
284.1
|
|
|
$
|
242.4
|
|
Europe
|
36.1
|
|
|
32.2
|
|
||
Rest of World
(3)(5)
|
1,003.1
|
|
|
996.8
|
|
||
Total
|
$
|
1,323.3
|
|
|
$
|
1,271.4
|
|
(1)
|
Revenues are attributed to regions based upon customer location.
|
(2)
|
Substantially all relates to operations in the United States.
|
(3)
|
Includes our operations in Asia Pacific, the Middle East and Latin America.
|
(4)
|
Long-lived assets include property and equipment, net of accumulated depreciation and amortization.
|
(5)
|
Substantially all of these long-lived assets relate to our operations in India.
|
|
|
|
|
|
|
Increase (Decrease)
|
||||||||
|
|
2016
|
|
2015
|
|
$
|
|
%
|
||||||
|
|
(Dollars in millions, except per share data)
|
||||||||||||
Revenues
|
|
$
|
3,453.2
|
|
|
$
|
3,187.0
|
|
|
$
|
266.2
|
|
|
8.4
|
Income from operations
|
|
583.4
|
|
|
542.8
|
|
|
40.6
|
|
|
7.5
|
|||
Net income
|
|
444.4
|
|
|
397.2
|
|
|
47.2
|
|
|
11.9
|
|||
Diluted earnings per share
|
|
0.73
|
|
|
0.65
|
|
|
0.08
|
|
|
|
|||
Other Financial Information
1
|
|
|
|
|
|
|
|
|
|
|||||
Non-GAAP income from operations
|
|
667.2
|
|
|
617.8
|
|
|
49.4
|
|
|
8.0
|
|||
Non-GAAP diluted earnings per share
|
|
0.86
|
|
|
0.76
|
|
|
0.10
|
|
|
|
•
|
Solid performance in our Other and Manufacturing/Retail/Logistics business segments with revenue growth of
13.6%
and
12.0%
, respectively;
|
•
|
Revenue in our Financial Services business segment grew
7.1%
as demand from our banking customers was negatively affected by the current macroeconomic conditions;
|
•
|
Revenue in our Healthcare business segment grew
5.7%
as the recent trend towards consolidation within the industry negatively affected demand from healthcare customers that were impacted by the mergers and acquisitions activity;
|
•
|
Sustained strength in the North American market where revenues grew
7.9%
;
|
•
|
Continued penetration of the European and Rest of World (primarily the Asia Pacific) markets. Revenue from our customers outside the United States was negatively affected by the strength of the U.S. dollar against the British pound:
|
◦
|
In Europe, we experienced revenue growth of
5.6%
, after a negative currency impact of 8.3%. Within the United Kingdom, we experienced revenue decline of
2.3%
, after a negative currency impact of 13.9%. Revenues from customers in the United Kingdom were negatively affected by the weakening of the British pound due to the result of the June 2016 United Kingdom referendum to exit the European Union, or Brexit Referendum. Revenues from our Rest of Europe customers increased
17.0%
with immaterial currency impact;
|
◦
|
Revenue from our Rest of World customers increased
23.2%
with immaterial currency impact;
|
•
|
Increased customer spending on discretionary projects;
|
1
|
Non-GAAP income from operations and Non-GAAP diluted earnings per share are not measurements of financial performance prepared in accordance with GAAP. See “Non-GAAP Financial Measures” for more information and a reconciliation to the most directly comparable GAAP financial measure.
|
•
|
Expansion of our service offerings, including consulting and digital services, next-generation IT solutions and platform-based solutions;
|
•
|
Continued expansion of the market for global delivery of IT and business process services; and
|
•
|
Increased penetration at existing customers, including strategic clients.
|
2
|
Non-GAAP operating margin is not a measurement of financial performance prepared in accordance with GAAP. See “Non-GAAP Financial Measures” for more information and a reconciliation to the most directly comparable GAAP financial measure.
|
•
|
Demand from our customers to help them meet their dual mandate of simultaneously achieving cost savings while investing in transformation and innovation;
|
•
|
Continued focus by customers on directing IT spending towards cost containment projects, such as application maintenance, infrastructure services and business process services;
|
•
|
Secular changes driven by evolving digital technologies and regulatory changes;
|
•
|
Demand from our banking customers may continue to be negatively affected by the current macroeconomic conditions affecting the industry, including a sustained low interest rate environment, the weakening of the British pound and uncertainty in the markets due to the results of the Brexit Referendum. These conditions may also impact revenue growth from our customers in other business segments;
|
•
|
Demand from our healthcare customers may continue to be negatively affected by the recent trend towards consolidation within the healthcare industry;
|
•
|
Discretionary spending by our retail customers may be affected by weakness in the retail sector;
|
•
|
Legal fees and other expenses related to the internal investigation and related matters as described above;
|
•
|
Volatility in foreign currency rates; and
|
•
|
Continued uncertainty in the world economy.
|
•
|
Continue to invest in our talent base and new service offerings, including digital technologies and new delivery models;
|
•
|
Partner with our existing customers to garner an increased portion of our customers’ overall IT spending by providing innovative solutions;
|
•
|
Focus on growing our business in Europe, the Middle East, the Asia Pacific and Latin America regions, where we believe there are opportunities to gain market share;
|
•
|
Increase our strategic customer base across all of our business segments;
|
•
|
Opportunistically look for acquisitions that may improve our overall service delivery capabilities, expand our geographic presence and/or enable us to enter new areas of technology;
|
•
|
Focus on operating discipline in order to appropriately manage our cost structure; and
|
•
|
Locate most of our new development center facilities in tax incentivized areas.
|
•
|
Financial Services, which includes customers providing banking/transaction processing, capital markets and insurance services;
|
•
|
Healthcare, which includes healthcare providers and payers as well as life sciences customers, including pharmaceutical, biotech and medical device companies;
|
•
|
Manufacturing/Retail/Logistics, which includes consumer goods manufacturers, retailers, travel and other hospitality customers, as well as customers providing logistics services; and
|
•
|
Other, which is an aggregation of industry operating segments each of which, individually, represents less than 10.0% of consolidated revenues and segment operating profit. The Other reportable segment includes our information, media and entertainment services, communications, and high technology operating segments.
|
|
|
|
% of
|
|
|
|
% of
|
|
Increase / Decrease
|
||||||||
|
2016
|
|
Revenues
|
|
2015
|
|
Revenues
|
|
$
|
|
%
|
||||||
|
(Dollars in millions, except per share data)
|
||||||||||||||||
Revenues
|
$
|
3,453.2
|
|
|
100.0
|
|
$
|
3,187.0
|
|
|
100.0
|
|
$
|
266.2
|
|
|
8.4
|
Cost of revenues
(1)
|
2,077.4
|
|
|
60.2
|
|
1,934.6
|
|
|
60.7
|
|
142.8
|
|
|
7.4
|
|||
Selling, general and administrative expenses
(1)
|
700.5
|
|
|
20.3
|
|
627.1
|
|
|
19.7
|
|
73.4
|
|
|
11.7
|
|||
Depreciation and amortization expense
|
91.9
|
|
|
2.7
|
|
82.5
|
|
|
2.6
|
|
9.4
|
|
|
11.4
|
|||
Income from operations
|
583.4
|
|
|
16.9
|
|
542.8
|
|
|
17.0
|
|
40.6
|
|
|
7.5
|
|||
Other income (expense), net
|
29.5
|
|
|
|
|
0.2
|
|
|
|
|
29.3
|
|
|
|
|||
Income before provision for income taxes
|
612.9
|
|
|
17.7
|
|
543.0
|
|
|
17.0
|
|
69.9
|
|
|
12.9
|
|||
Provision for income taxes
|
(168.9
|
)
|
|
|
|
(145.8
|
)
|
|
|
|
(23.1
|
)
|
|
15.8
|
|||
Income from equity method investment
|
0.4
|
|
|
|
|
—
|
|
|
|
|
0.4
|
|
|
|
|||
Net income
|
$
|
444.4
|
|
|
12.9
|
|
$
|
397.2
|
|
|
12.5
|
|
$
|
47.2
|
|
|
11.9
|
Diluted earnings per share
|
$
|
0.73
|
|
|
|
|
$
|
0.65
|
|
|
|
|
$
|
0.08
|
|
|
|
Other Financial Information
(2)
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Non-GAAP income from operations and non-GAAP operating margin
|
$
|
667.2
|
|
|
19.3
|
|
$
|
617.8
|
|
|
19.4
|
|
$
|
49.4
|
|
|
8.0
|
Non-GAAP diluted earnings per share
|
$
|
0.86
|
|
|
|
|
$
|
0.76
|
|
|
|
|
$
|
0.10
|
|
|
|
(1)
|
Exclusive of depreciation and amortization expense.
|
(2)
|
Non-GAAP income from operations, non-GAAP operating margin and non-GAAP diluted earnings per share are not measurements of financial performance prepared in accordance with GAAP. See “Non-GAAP Financial Measures” for more information and a reconciliation to the most directly comparable GAAP financial measure.
|
|
|
2016
|
|
2015
|
|
Increase
|
||||||||
$
|
|
%
|
||||||||||||
|
|
(Dollars in millions)
|
||||||||||||
Financial Services
|
|
$
|
1,375.4
|
|
|
$
|
1,284.0
|
|
|
$
|
91.4
|
|
|
7.1
|
Healthcare
|
|
992.8
|
|
|
939.2
|
|
|
53.6
|
|
|
5.7
|
|||
Manufacturing/Retail/Logistics
|
|
678.7
|
|
|
606.2
|
|
|
72.5
|
|
|
12.0
|
|||
Other
|
|
406.3
|
|
|
357.6
|
|
|
48.7
|
|
|
13.6
|
|||
Total revenues
|
|
$
|
3,453.2
|
|
|
$
|
3,187.0
|
|
|
$
|
266.2
|
|
|
8.4
|
|
|
2016
|
|
2015
|
|
Increase (Decrease)
|
|||||||||
|
$
|
|
%
|
||||||||||||
|
|
(Dollars in millions)
|
|||||||||||||
North America
|
|
$
|
2,709.4
|
|
|
$
|
2,510.6
|
|
|
$
|
198.8
|
|
|
7.9
|
|
United Kingdom
|
|
293.0
|
|
|
299.9
|
|
|
(6.9
|
)
|
|
(2.3
|
)
|
|||
Rest of Europe
|
|
244.7
|
|
|
209.2
|
|
|
35.5
|
|
|
17.0
|
|
|||
Europe - Total
|
|
537.7
|
|
|
509.1
|
|
|
28.6
|
|
|
5.6
|
|
|||
Rest of World
|
|
206.1
|
|
|
167.3
|
|
|
38.8
|
|
|
23.2
|
|
|||
Total revenues
|
|
$
|
3,453.2
|
|
|
$
|
3,187.0
|
|
|
$
|
266.2
|
|
|
8.4
|
|
|
|
|
|
|
Increase (Decrease)
|
|||||||||
|
2016
|
|
2015
|
|
$
|
|
%
|
|||||||
|
(Dollars in millions)
|
|||||||||||||
Financial Services
|
$
|
433.1
|
|
|
$
|
430.0
|
|
|
$
|
3.1
|
|
|
0.7
|
|
Healthcare
|
314.2
|
|
|
322.8
|
|
|
(8.6
|
)
|
|
(2.7
|
)
|
|||
Manufacturing/Retail/Logistics
|
213.5
|
|
|
215.5
|
|
|
(2.0
|
)
|
|
(0.9
|
)
|
|||
Other
|
118.4
|
|
|
117.3
|
|
|
1.1
|
|
|
0.9
|
|
|||
Total segment operating profit
|
1,079.2
|
|
|
1,085.6
|
|
|
(6.4
|
)
|
|
(0.6
|
)
|
|||
Less: unallocated costs
|
495.8
|
|
|
542.8
|
|
|
(47.0
|
)
|
|
(8.7
|
)
|
|||
Income from operations
|
$
|
583.4
|
|
|
$
|
542.8
|
|
|
$
|
40.6
|
|
|
7.5
|
|
|
2016
|
|
2015
|
|
Increase/
Decrease
|
||||||
|
(in millions)
|
||||||||||
Foreign currency exchange gains (losses)
|
$
|
12.4
|
|
|
$
|
(19.0
|
)
|
|
$
|
31.4
|
|
(Losses) gains on foreign exchange forward contracts not designated as hedging instruments
|
(5.5
|
)
|
|
3.2
|
|
|
(8.7
|
)
|
|||
Foreign currency exchange gains (losses), net
|
6.9
|
|
|
(15.8
|
)
|
|
22.7
|
|
|||
Interest income
|
27.2
|
|
|
20.7
|
|
|
6.5
|
|
|||
Interest expense
|
(4.9
|
)
|
|
(4.3
|
)
|
|
(0.6
|
)
|
|||
Other, net
|
0.3
|
|
|
(0.4
|
)
|
|
0.7
|
|
|||
Total other income (expense), net
|
$
|
29.5
|
|
|
$
|
0.2
|
|
|
$
|
29.3
|
|
3
|
Non-GAAP operating margin is not a measurement of financial performance prepared in accordance with GAAP. See “Non-GAAP Financial Measures” for more information and a reconciliation to the most directly comparable GAAP financial measure.
|
|
2016
|
|
% of
Revenues
|
|
2015
|
|
% of
Revenues
|
||||
|
(Dollars in millions, except per share amounts)
|
||||||||||
GAAP income from operations and operating margin
|
$
|
583.4
|
|
|
16.9
|
|
$
|
542.8
|
|
|
17.0
|
Add: Stock-based compensation expense
|
49.7
|
|
|
1.4
|
|
46.4
|
|
|
1.5
|
||
Add: Acquisition-related charges
(1)
|
34.1
|
|
|
1.0
|
|
28.6
|
|
|
0.9
|
||
Non-GAAP income from operations and non-GAAP operating margin
|
$
|
667.2
|
|
|
19.3
|
|
$
|
617.8
|
|
|
19.4
|
|
|
|
|
|
|
|
|
||||
GAAP diluted earnings per share
|
$
|
0.73
|
|
|
|
|
$
|
0.65
|
|
|
|
Effect of above operating adjustments, net of tax
(2)
|
0.10
|
|
|
|
|
0.09
|
|
|
|
||
Effect of non-operating foreign currency exchange (gains) losses, net of tax
(3)
|
(0.01
|
)
|
|
|
|
0.02
|
|
|
|
||
Effect of incremental income tax expense related to the India Cash Remittance
(4)
|
0.04
|
|
|
|
|
—
|
|
|
|
||
Non-GAAP diluted earnings per share
|
$
|
0.86
|
|
|
|
|
$
|
0.76
|
|
|
|
(1)
|
Acquisition-related charges include, when applicable, amortization of purchased intangible assets included in the depreciation and amortization expense line on our condensed consolidated statements of operations, external deal costs, acquisition-related retention bonuses, integration costs, changes in the fair value of contingent consideration liabilities, charges for impairment of acquired intangible assets and other acquisition-related costs.
|
(2)
|
The non-GAAP income tax benefits related to stock-based compensation expense were
$10.1 million
and
$11.2 million
for the three months ended September 30, 2016 and 2015, respectively.
|
(3)
|
Non-operating foreign currency exchange gains and losses are inclusive of gains and losses on related foreign exchange forward contracts not designated as hedging instruments for accounting purposes. For the three months ended September 30, 2016, the non-GAAP pre-tax non-operating foreign currency exchange gains were
$6.9 million
with related incremental non-GAAP income tax benefits of
$2.1 million
. For the three months ended September 30, 2015, the non-GAAP pre-tax non-operating foreign currency exchange losses were
$15.8 million
with related incremental non-GAAP income tax expense of
$0.7 million
. The effective tax rate related to the reported non-operating foreign currency exchange gains and losses varies depending on the jurisdictions in which such gains and losses are generated and the statutory rates applicable in those jurisdictions.
|
(4)
|
In May 2016, our principal operating subsidiary in India repurchased shares from its shareholders, which are non-Indian Cognizant entities, valued at $2.8 billion. As a result of this transaction, we will incur an incremental 2016 income tax expense of $237.5 million, of which $190.0 million was recognized in the quarter ended June 30, 2016, $23.7 million was recognized in the quarter ended September 30, 2016 and $23.8 million will be recognized in the quarter ending December 31, 2016.
|
|
|
|
% of
|
|
|
|
% of
|
|
Increase / Decrease
|
|||||||||
|
2016
|
|
Revenues
|
|
2015
|
|
Revenues
|
|
$
|
|
%
|
|||||||
|
(Dollars in millions, except per share data)
|
|||||||||||||||||
Revenues
|
$
|
10,025.1
|
|
|
100.0
|
|
$
|
9,183.5
|
|
|
100.0
|
|
$
|
841.6
|
|
|
9.2
|
|
Cost of revenues
(1)
|
6,030.5
|
|
|
60.2
|
|
5,506.6
|
|
|
60.0
|
|
523.9
|
|
|
9.5
|
|
|||
Selling, general and administrative expenses
(1)
|
2,000.6
|
|
|
20.0
|
|
1,849.9
|
|
|
20.1
|
|
150.7
|
|
|
8.1
|
|
|||
Depreciation and amortization expense
|
265.7
|
|
|
2.7
|
|
238.4
|
|
|
2.6
|
|
27.3
|
|
|
11.5
|
|
|||
Income from operations
|
1,728.3
|
|
|
17.2
|
|
1,588.6
|
|
|
17.3
|
|
139.7
|
|
|
8.8
|
|
|||
Other income (expense), net
|
68.3
|
|
|
|
|
13.8
|
|
|
|
|
54.5
|
|
|
394.9
|
|
|||
Income before provision for income taxes
|
1,796.6
|
|
|
17.9
|
|
1,602.4
|
|
|
17.4
|
|
194.2
|
|
|
12.1
|
|
|||
Provision for income taxes
|
(659.2
|
)
|
|
|
|
(402.2
|
)
|
|
|
|
(257.0
|
)
|
|
63.9
|
|
|||
Income from equity method investment
|
0.6
|
|
|
|
|
—
|
|
|
|
|
0.6
|
|
|
|
|
|||
Net income
|
$
|
1,138.0
|
|
|
11.4
|
|
$
|
1,200.2
|
|
|
13.1
|
|
$
|
(62.2
|
)
|
|
(5.2
|
)
|
Diluted earnings per share
|
$
|
1.87
|
|
|
|
|
$
|
1.96
|
|
|
|
|
$
|
(0.09
|
)
|
|
|
|
Other Financial Information
(2)
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Non-GAAP income from operations and non-GAAP operating margin
|
$
|
1,987.2
|
|
|
19.8
|
|
$
|
1,817.5
|
|
|
19.8
|
|
$
|
169.7
|
|
|
9.3
|
|
Non-GAAP diluted earnings per share
|
$
|
2.53
|
|
|
|
|
$
|
2.27
|
|
|
|
|
$
|
0.26
|
|
|
|
(1)
|
Exclusive of depreciation and amortization expense.
|
(2)
|
Non-GAAP income from operations, non-GAAP operating margin and non-GAAP diluted earnings per share are not measurements of financial performance prepared in accordance with GAAP. See “Non-GAAP Financial Measures” for more information and a reconciliation to the most directly comparable GAAP financial measure.
|
|
|
2016
|
|
2015
|
|
Increase
|
||||||||
$
|
|
%
|
||||||||||||
|
|
(Dollars in millions)
|
||||||||||||
Financial Services
|
|
$
|
4,012.3
|
|
|
$
|
3,695.2
|
|
|
$
|
317.1
|
|
|
8.6
|
Healthcare
|
|
2,865.7
|
|
|
2,715.6
|
|
|
150.1
|
|
|
5.5
|
|||
Manufacturing/Retail/Logistics
|
|
1,971.6
|
|
|
1,733.4
|
|
|
238.2
|
|
|
13.7
|
|||
Other
|
|
1,175.5
|
|
|
1,039.3
|
|
|
136.2
|
|
|
13.1
|
|||
Total revenues
|
|
$
|
10,025.1
|
|
|
$
|
9,183.5
|
|
|
$
|
841.6
|
|
|
9.2
|
|
|
2016
|
|
2015
|
|
Increase
|
||||||||
$
|
|
%
|
||||||||||||
|
|
(Dollars in millions)
|
||||||||||||
North America
|
|
$
|
7,830.8
|
|
|
$
|
7,226.5
|
|
|
$
|
604.3
|
|
|
8.4
|
United Kingdom
|
|
902.5
|
|
|
882.6
|
|
|
19.9
|
|
|
2.3
|
|||
Rest of Europe
|
|
707.8
|
|
|
604.7
|
|
|
103.1
|
|
|
17.0
|
|||
Europe - Total
|
|
1,610.3
|
|
|
1,487.3
|
|
|
123.0
|
|
|
8.3
|
|||
Rest of World
|
|
584.0
|
|
|
469.7
|
|
|
114.3
|
|
|
24.3
|
|||
Total revenues
|
|
$
|
10,025.1
|
|
|
$
|
9,183.5
|
|
|
$
|
841.6
|
|
|
9.2
|
|
|
|
|
|
Increase (Decrease)
|
|||||||||
|
2016
|
|
2015
|
|
$
|
|
%
|
|||||||
|
(Dollars in millions)
|
|||||||||||||
Financial Services
|
$
|
1,315.4
|
|
|
$
|
1,197.5
|
|
|
$
|
117.9
|
|
|
9.8
|
|
Healthcare
|
879.4
|
|
|
885.4
|
|
|
(6.0
|
)
|
|
(0.7
|
)
|
|||
Manufacturing/Retail/Logistics
|
658.8
|
|
|
598.0
|
|
|
60.8
|
|
|
10.2
|
|
|||
Other
|
374.0
|
|
|
332.2
|
|
|
41.8
|
|
|
12.6
|
|
|||
Total segment operating profit
|
3,227.6
|
|
|
3,013.1
|
|
|
214.5
|
|
|
7.1
|
|
|||
Less: unallocated costs
|
1,499.3
|
|
|
1,424.5
|
|
|
74.8
|
|
|
5.3
|
|
|||
Income from operations
|
$
|
1,728.3
|
|
|
$
|
1,588.6
|
|
|
$
|
139.7
|
|
|
8.8
|
|
4
|
Non-GAAP operating margin is not a measurement of financial performance prepared in accordance with GAAP. See “Non-GAAP Financial Measures” for more information and a reconciliation to the most directly comparable GAAP financial measure.
|
|
2016
|
|
2015
|
|
Increase/
Decrease
|
||||||
|
(in millions)
|
||||||||||
Foreign currency exchange gains (losses)
|
$
|
1.6
|
|
|
$
|
(29.9
|
)
|
|
$
|
31.5
|
|
(Losses) gains on foreign exchange forward contracts not designated as hedging instruments
|
(5.8
|
)
|
|
1.5
|
|
|
(7.3
|
)
|
|||
Foreign currency exchange (losses), net
|
(4.2
|
)
|
|
(28.4
|
)
|
|
24.2
|
|
|||
Interest income
|
85.4
|
|
|
56.3
|
|
|
29.1
|
|
|||
Interest expense
|
(14.6
|
)
|
|
(13.4
|
)
|
|
(1.2
|
)
|
|||
Other, net
|
1.7
|
|
|
(0.7
|
)
|
|
2.4
|
|
|||
Total other income (expense), net
|
$
|
68.3
|
|
|
$
|
13.8
|
|
|
$
|
54.5
|
|
|
2016
|
|
% of
Revenues
|
|
2015
|
|
% of
Revenues
|
||||
|
(Dollars in millions, except per share amounts)
|
||||||||||
GAAP income from operations and operating margin
|
$
|
1,728.3
|
|
|
17.2
|
|
$
|
1,588.6
|
|
|
17.3
|
Add: Stock-based compensation expense
|
165.4
|
|
|
1.7
|
|
141.6
|
|
|
1.5
|
||
Add: Acquisition-related charges
(1)
|
93.5
|
|
|
0.9
|
|
87.3
|
|
|
1.0
|
||
Non-GAAP income from operations and non-GAAP operating margin
|
$
|
1,987.2
|
|
|
19.8
|
|
$
|
1,817.5
|
|
|
19.8
|
|
|
|
|
|
|
|
|
||||
GAAP diluted earnings per share
|
$
|
1.87
|
|
|
|
|
$
|
1.96
|
|
|
|
Effect of above operating adjustments, net of tax
(2)
|
0.31
|
|
|
|
|
0.26
|
|
|
|
||
Effect of non-operating foreign currency exchange losses, net of tax
(3)
|
—
|
|
|
|
|
0.05
|
|
|
|
||
Effect of incremental income tax expense related to the India Cash Remittance
(4)
|
0.35
|
|
|
|
|
—
|
|
|
|
||
Non-GAAP diluted earnings per share
|
$
|
2.53
|
|
|
|
|
$
|
2.27
|
|
|
|
(1)
|
Acquisition-related charges include, when applicable, amortization of purchased intangible assets included in the depreciation and amortization expense line on our condensed consolidated statements of operations, external deal costs, acquisition-related retention bonuses, integration costs, changes in the fair value of contingent consideration liabilities, charges for impairment of acquired intangible assets and other acquisition-related costs.
|
(2)
|
The non-GAAP income tax benefits related to stock-based compensation expense were
$36.8 million
and
$34.3 million
for the nine months ended September 30, 2016 and 2015, respectively.
|
(3)
|
Non-operating foreign currency exchange gains and losses are inclusive of gains and losses on related foreign exchange forward contracts not designated as hedging instruments for accounting purposes. The non-GAAP pre-tax non-operating foreign currency exchange losses were
$4.2 million
and
$28.4 million
for the nine months ended September 30, 2016 and 2015, respectively, with related non-GAAP tax benefits of
$3.1 million
and
$0.1 million
, respectively. The effective tax rate related to the reported non-operating foreign currency exchange gains and losses varies depending on the jurisdictions in which such gains and losses are generated and the statutory rates applicable in those jurisdictions.
|
(4)
|
In May 2016, our principal operating subsidiary in India repurchased shares from its shareholders, which are non-Indian Cognizant entities, valued at $2.8 billion. As a result of this transaction, we will incur an incremental 2016 income tax expense of $237.5 million, of which $213.7 million was recognized in the nine months ended September 30, 2016 and $23.8 million will be recognized in the quarter ending December 31, 2016.
|
|
|
2016
|
|
2015
|
|
Increase / Decrease
|
||||||
|
|
(in millions)
|
||||||||||
Net cash from operating activities
|
|
$
|
1,022.4
|
|
|
$
|
1,463.3
|
|
|
$
|
(440.9
|
)
|
Net cash (used in) investing activities
|
|
(872.7
|
)
|
|
(1,030.4
|
)
|
|
157.7
|
|
|||
Net cash (used in) financing activities
|
|
(729.6
|
)
|
|
(954.9
|
)
|
|
225.3
|
|
|
Notional Value (in millions)
|
|
Weighted Average Contract Rate (Indian rupee to U.S. dollar)
|
|||
2016
|
$
|
315.0
|
|
|
69.5
|
|
2017
|
1,125.0
|
|
|
71.5
|
|
|
2018
|
495.0
|
|
|
73.9
|
|
|
Total
|
$
|
1,935.0
|
|
|
71.8
|
|
•
|
Competition from other service providers;
|
•
|
The risk that our operating margin may decline and we may not be able to sustain our current level of profitability;
|
•
|
The risk of liability or damage to our reputation resulting from security breaches;
|
•
|
Any possible failure to comply with or adapt to changes in healthcare-related data protection and privacy laws;
|
•
|
The loss of customers, especially as a few customers account for a large portion of our revenues;
|
•
|
The risk that we may not be able to keep pace with the rapidly evolving technological environment;
|
•
|
The rate of growth in the use of technology in business and the type and level of technology spending by our clients;
|
•
|
Mispricing of our services, especially as an increasing percentage of our revenues are derived from fixed-price contracts;
|
•
|
Our inability to successfully acquire or integrate target companies;
|
•
|
System failure or disruptions in our communications or information technology;
|
•
|
Risks associated with our ongoing internal investigation into possible violations of the Foreign Corrupt Practices Act and similar laws, including sanctions, fines or remedial measures that may be imposed by the DOJ or SEC, additional expenses related to remedial measures, the costs of defending and possible judgments against us that may result from associated lawsuits against us and any possible impact on our ability to timely file the required reports with the SEC;
|
•
|
Risks associated with our identified material weakness in internal control over financial reporting and any other failure to maintain effective internal controls, including any potential future findings of control deficiencies through the internal investigation, as a we acquire and integrate other companies or otherwise;
|
•
|
The risk that we may lose key executives and not be able to enforce non-competition agreements with them;
|
•
|
Competition for hiring highly-skilled technical personnel;
|
•
|
Possible failure to provide end-to-end business solutions and deliver complex and large projects for our clients;
|
•
|
The risk of reputational harm to us;
|
•
|
Our revenues being highly dependent on clients concentrated in certain industries, including financial services and healthcare, and located primarily in the United States and Europe;
|
•
|
Risks relating to our global operations, including our operations in India;
|
•
|
The effects of fluctuations in the Indian rupee and other currency exchange rates;
|
•
|
The effect of our use of derivative instruments;
|
•
|
The risk of war, terrorist activities, pandemics and natural disasters;
|
•
|
The possibility that we may be required, as a result of our indebtedness, or otherwise choose to repatriate foreign earnings or that our foreign earnings or profits may become subject to U.S. taxes;
|
•
|
The possibility that we may lose certain tax benefits provided to companies in our industry by the Indian government;
|
•
|
The risk that we may not be able to enforce or protect our intellectual property rights, or that we may infringe upon the intellectual property rights of others;
|
•
|
Changes in domestic and international regulations and legislation relating to immigration and anti-outsourcing;
|
•
|
Increased regulation of the financial services and healthcare industries, as well as other industries in which our clients operate;
|
•
|
The Brexit Referendum and any negative effects on global economic conditions, financial markets and our business; and
|
•
|
The factors set forth in Part I, in the section entitled “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2015.
|
|
Notional Value (in millions)
|
|
Weighted Average Contract Rate (Indian rupee to U.S. dollar)
|
|||
2016
|
$
|
315.0
|
|
|
69.5
|
|
2017
|
1,125.0
|
|
|
71.5
|
|
|
2018
|
495.0
|
|
|
73.9
|
|
|
Total
|
$
|
1,935.0
|
|
|
71.8
|
|
Month
|
|
Total Number
of Shares Purchased |
|
Average
Price Paid per Share |
|
Total Number of
Shares Purchased as Part of Publicly Announced Plans or Programs |
|
Approximate
Dollar Value of Shares that May Yet Be Purchased under the Plans or Programs (in millions) |
||||||
July 1, 2016 - July 31, 2016
|
|
866,190
|
|
|
$
|
57.72
|
|
|
866,190
|
|
|
$
|
93.3
|
|
August 1, 2016 - August 31, 2016
|
|
1,650,000
|
|
|
57.52
|
|
|
1,650,000
|
|
|
998.4
|
|
||
September 1, 2016 - September 30, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
998.4
|
|
||
Total
|
|
2,516,190
|
|
|
$
|
57.59
|
|
|
2,516,190
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
Incorporated by Reference
|
|
|
|||||||
Number
|
|
Exhibit Description
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Date
|
|
Filed or Furnished Herewith
|
|
3.1
|
|
Restated Certificate of Incorporation
|
|
8-K
|
|
000-24429
|
|
3.2
|
|
|
9/17/2013
|
|
|
3.2
|
|
Amended and Restated Bylaws, as adopted on January 28, 2016
|
|
8-K
|
|
000-24429
|
|
3.2
|
|
|
2/1/2016
|
|
|
10.1
|
|
Amendment No. 1 and Limited Waiver No. 1 to the Credit Agreement, dated as of November 5, 2016 among Cognizant Technology Solutions Corporation, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent for the lenders
|
|
|
|
|
|
|
|
|
|
Filed
|
|
31.1
|
|
Certification of principal executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
|
|
Filed
|
|
31.2
|
|
Certification of principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
|
|
Filed
|
|
32.1
|
|
Certification of principal executive officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. 1350
|
|
|
|
|
|
|
|
|
|
Furnished
|
|
32.2
|
|
Certification of principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. 1350
|
|
|
|
|
|
|
|
|
|
Furnished
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
|
|
Filed
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
|
|
Filed
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
|
Filed
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
|
|
Filed
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
|
|
Filed
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
|
Filed
|
|
|
|
Cognizant Technology Solutions Corporation
|
|||
|
|
|
|
|
||
Date:
|
November 7, 2016
|
|
|
By:
|
|
/s/ Francisco D’Souza
|
|
|
|
|
|
|
Francisco D’Souza,
|
|
|
|
|
|
|
Chief Executive Officer
|
|
|
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
Date:
|
November 7, 2016
|
|
|
By:
|
|
/s/ Karen McLoughlin
|
|
|
|
|
|
|
Karen McLoughlin,
|
|
|
|
|
|
|
Chief Financial Officer
|
|
|
|
|
|
|
(Principal Financial and Accounting Officer)
|
|
|
|
|
Incorporated by Reference
|
|
|
||||||
Number
|
|
Exhibit Description
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Date
|
|
Filed or Furnished Herewith
|
3.1
|
|
Restated Certificate of Incorporation
|
|
8-K
|
|
000-24429
|
|
3.2
|
|
9/17/2013
|
|
|
3.2
|
|
Amended and Restated Bylaws, as adopted on January 28, 2016
|
|
8-K
|
|
000-24429
|
|
3.2
|
|
2/1/2016
|
|
|
10.1
|
|
Amendment No. 1 and Limited Waiver No. 1 to the Credit Agreement, dated as of November 5, 2016 among Cognizant Technology Solutions Corporation, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent for the lenders
|
|
|
|
|
|
|
|
|
|
Filed
|
31.1
|
|
Certification of principal executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
|
|
Filed
|
31.2
|
|
Certification of principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
|
|
Filed
|
32.1
|
|
Certification of principal executive officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. 1350
|
|
|
|
|
|
|
|
|
|
Furnished
|
32.2
|
|
Certification of principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. 1350
|
|
|
|
|
|
|
|
|
|
Furnished
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
|
|
Filed
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
|
|
Filed
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
|
Filed
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
|
|
Filed
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
|
|
Filed
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
|
Filed
|
By:
|
/s/ Karen McLoughlin
|
Name:
|
Karen McLoughlin
|
Title:
|
Chief Financial Officer
|
By:
|
/s/ Daglas P Panchal
|
Name:
|
Daglas P Panchal
|
Title:
|
Vice President
|
By:
|
/s/ Daglas P Panchal
|
Name:
|
Daglas P Panchal
|
Title:
|
Vice President
|
By:
|
/s/ James M. Walsh
|
Name:
|
James M. Walsh
|
Title:
|
Vice President & Managing Director
|
By:
|
/s/ Nicholas Bozich
|
Name:
|
Nicholas Bozich
|
Title:
|
Officer
|
By:
|
/s/ Jake Lam
|
Name:
|
Jake Lam
|
Title:
|
Assistant Vice President
|
By:
|
/s/ Judith Smith
|
Name:
|
Judith Smith
|
Title:
|
Authorized Signatory
|
By:
|
/s/ Joan Park
|
Name:
|
Joan Park
|
Title:
|
Authorized Signatory
|
By:
|
/s/ Steven Thompson
|
Name:
|
Steven Thompson
|
Title:
|
Assistant Vice President
|
By:
|
/s/ Lillian Kim
|
Name:
|
Lillian Kim
|
Title:
|
Director
|
By:
|
/s/ Laura H. McAulay
|
Name:
|
Laura H. McAulay
|
Title:
|
Senior Vice President
|
By:
|
/s/ Karen H. McClain
|
Name:
|
Karen H. McClain
|
Title:
|
Managing Director
|
By:
|
/s/ Mark Hogan
|
Name:
|
Mark Hogan
|
Title:
|
Senior Vice President
|
By:
|
/s/ Cecile Segovia
|
Name:
|
Cecile Segovia
|
Title:
|
Director
|
By:
|
/s/ Mathew Harvey
|
Name:
|
Mathew Harvey
|
Title:
|
Managing Director
|
By:
|
/s/ Thuy Bui
|
Name:
|
Thuy Bui
|
Title:
|
Vice President
|
By:
|
/s/ James Weinstein
|
Name:
|
James Weinstein
|
Title:
|
Managing Director
|
By:
|
/s/ Thomas J. Tarasovich Jr
|
Name:
|
Thomas J. Tarasovich, Jr.
|
Title:
|
Vice President
|
By:
|
/s/ Nigel Elvey
|
Name:
|
Nigel Elvey
|
Title:
|
Director, Corporate Credit Group
|
By:
|
/s/ Kamran Khan
|
Name:
|
Kamran Khan
|
Title:
|
Authorized Signatory
|
By:
|
/s/ Michael Thilmany
|
Name:
|
Michael Thilmany
|
Title:
|
Director
|
By:
|
/s/ Erin Walsh
|
Name:
|
Erin Walsh
|
Title:
|
Assistant Vice President
|
By:
|
/s/ Daven Popat
|
Name:
|
Daven Popat
|
Title:
|
Senior Vice President
|
By:
|
/s/ David A. Wild
|
Name:
|
David A. Wild
|
Title:
|
Senior Vice President
|
By:
|
/s/ Carlos Cruz
|
Name:
|
Carlos Cruz
|
Title:
|
Vice President
|
1.
|
I have reviewed this Quarterly Report on Form 10-Q of Cognizant Technology Solutions Corporation;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
|
|
|
|
|
Dated:
|
November 7, 2016
|
|
/s/ Francisco D’Souza
|
|
|
|
|
Francisco D’Souza,
|
|
|
|
|
Chief Executive Officer
(Principal Executive Officer)
|
|
1.
|
I have reviewed this Quarterly Report on Form 10-Q of Cognizant Technology Solutions Corporation;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Dated:
|
November 7, 2016
|
|
/s/ Karen McLoughlin
|
|
|
|
|
Karen McLoughlin
|
|
|
|
|
Chief Financial Officer
(Principal Financial and Accounting Officer)
|
Dated:
|
November 7, 2016
|
|
/s/ Francisco D’Souza
|
|
|
|
|
Francisco D’Souza,
|
|
|
|
|
Chief Executive Officer
(Principal Executive Officer)
|
|
*
|
A signed original of this written statement required by Section 906 has been provided to Cognizant Technology Solutions Corporation and will be retained by Cognizant Technology Solutions Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
|
Dated:
|
November 7, 2016
|
|
/s/ Karen McLoughlin
|
|
|
|
|
Karen McLoughlin
|
|
|
|
|
Chief Financial Officer
(Principal Financial and Accounting Officer)
|
*
|
A signed original of this written statement required by Section 906 has been provided to Cognizant Technology Solutions Corporation and will be retained by Cognizant Technology Solutions Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
|